Loading companies…
Loading companies…
United States · Biotech · Healthtech
Develops potent and durable mRNA medicines using the APEXm platform for autoimmune and oncology
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Seed | $13M | Breyer Capital — Role not disclosedGeneral Catalyst — Role not disclosedMetaplanet — Role not disclosedSurgePoint Capital — Role not disclosedY Combinator (YC) — Role not disclosedZAKA VC — Role not disclosed |